Pharvaris N.V.
PHVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001830487
In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 18 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.
Q2 2026 vs. Q1 2026
How the institutions holding Pharvaris N.V. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 110 | 125 | +15 |
| Shares | 59.1M | 64.5M | +5.44M (+9.2%) |
| Value | $1.67B | $2.23B | +$562.2M (+33.7%) |
New holders (24)
Institutions that held Pharvaris N.V. at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (9)
Institutions that held Pharvaris N.V. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Baker Bros. Advisors LP | 375,000 | $10.6M |
| Schroder Investment Management Group | 158,019 | $4.31M |
| DV Trading LLC | 143,966 | $4.07M |
| Great Point Partners LLC | 82,800 | $2.34M |
| UBS Asset Management Americas Inc | 77,646 | $2.19M |
| Logos Global Management LP | 65,000 | $1.84M |
| Alps Advisors Inc | 52,148 | $1.47M |
| Jump Financial, LLC | 19,500 | $550.9K |
| Quadrature Capital Ltd | 13,723 | $387.7K |